Phreesia (NYSE:PHR) Reaches New 12-Month Low Following Insider Selling

Phreesia, Inc. (NYSE:PHR) shares reached a new 52-week low during trading on Wednesday following insider selling activity. The stock traded as low as $15.40 and last traded at $15.6190, with a volume of 349032 shares. The stock had previously closed at $15.73.

Specifically, CFO Balaji Gandhi sold 4,687 shares of Phreesia stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $76,679.32. Following the completion of the transaction, the chief financial officer directly owned 150,569 shares of the company’s stock, valued at approximately $2,463,308.84. The trade was a 3.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Allison C. Hoffman sold 3,995 shares of the stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $65,358.20. Following the sale, the general counsel owned 169,661 shares in the company, valued at approximately $2,775,653.96. The trade was a 2.30% decrease in their position. The SEC filing for this sale provides additional information. In related news, insider David Linetsky sold 6,038 shares of the business’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $98,781.68. Following the completion of the transaction, the insider directly owned 223,942 shares in the company, valued at $3,663,691.12. The trade was a 2.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Analyst Upgrades and Downgrades

PHR has been the subject of several recent analyst reports. BMO Capital Markets started coverage on Phreesia in a research note on Thursday, November 13th. They issued an “outperform” rating and a $32.00 price target for the company. Needham & Company LLC reissued a “buy” rating and issued a $35.00 target price on shares of Phreesia in a research report on Monday, December 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. JPMorgan Chase & Co. reduced their price target on shares of Phreesia from $32.00 to $29.00 and set an “overweight” rating for the company in a research note on Tuesday, December 9th. Finally, Canaccord Genuity Group decreased their price objective on shares of Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a report on Tuesday, December 9th. Seventeen investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.06.

Phreesia News Summary

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Recent operating results show improvement: Phreesia beat consensus EPS and reported revenue growth (quarterly revenue up ~12.7% year‑over‑year), supporting the business case for recovery at current multiples. MarketBeat PHR profile
• Positive Sentiment: Wall Street remains largely constructive — most analysts rate PHR a Buy and the consensus price target (~$30) is well above the current trading level, giving upside if growth continues. Analyst consensus
• Neutral Sentiment: Although insiders sold sizable blocks, each still retains a material stake after the trades (examples from filings: Evan Roberts ~826k, David Linetsky ~224k, Allison Hoffman ~170k, Balaji Gandhi ~150k, Amy Vanduyn ~159k), which may temper concerns about a loss of long‑term conviction. InsiderTrades summary
• Neutral Sentiment: Market context: volume is slightly above average and the stock is trading below its 50‑ and 200‑day moving averages and near its 52‑week low — conditions that can amplify moves but also offer a potential entry if fundamentals improve. Price performance
• Negative Sentiment: Coordinated insider selling is the primary near‑term driver of weakness: multiple senior executives sold on Jan 15–16 at ~ $16.36–$16.38 (combined ~29,511 shares). Visible, same‑period sales by several officers can prompt short‑term selling pressure as other holders react. Evan Roberts sale (example)
• Negative Sentiment: Insider sales may be interpreted as liquidity or diversification events rather than vote of no confidence, but absent clarifying disclosure (e.g., 10b5‑1 plans, option exercises) the market tends to treat clustered insider sales as a negative signal. SEC filings

Phreesia Trading Down 0.9%

The stock has a 50 day moving average of $17.94 and a 200-day moving average of $23.03. The company has a market capitalization of $939.62 million, a P/E ratio of -155.83 and a beta of 0.61. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.11. The company had revenue of $120.33 million for the quarter, compared to analysts’ expectations of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. Phreesia’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.25) EPS. On average, research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Trading of Phreesia

Several hedge funds have recently bought and sold shares of the stock. Federated Hermes Inc. purchased a new stake in shares of Phreesia in the third quarter worth about $32,000. Asset Management One Co. Ltd. bought a new stake in Phreesia in the 3rd quarter worth approximately $45,000. State of Alaska Department of Revenue purchased a new stake in shares of Phreesia during the 3rd quarter worth approximately $83,000. Farther Finance Advisors LLC boosted its position in shares of Phreesia by 9,375.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after acquiring an additional 3,000 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new position in shares of Phreesia during the 3rd quarter valued at approximately $118,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.